In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cellegy Pharmaceuticals Inc.

Division of Adamis Pharmaceuticals Corp.
www.cellegy.com

Latest From Cellegy Pharmaceuticals Inc.

Adamis and La Jolla Pharmaceutical to merge

Adamis Pharmaceuticals has entered a merger agreement to acquire fellow US firm La Jolla Pharmaceutical Company. The deal has been approved by both boards of directors and, subject to closing conditions including shareholder approval, is expected to close in the first quarter of next year.

Companies Deals

Europe's New Spec Pharma Models

Spec pharma has created significant value in the US, but not, so far, in Europe. Still, Europe's spec pharma hopefuls aren't giving up, and they're trying out variations on the theme--some starting with infrastructure, others with products.
Europe North America

Ex-Shire Team Builds New Euro-Specialty Group

Archimedes joins a growing new generation of pan-European specialty pharma, highlighting the need for a single commercial partner across Europe and the increasing alternatives to big and mid-sized pharma.
BioPharmaceutical Strategy

Europe's Flavors of Sustainable BioPharma

Europe's financing environment makes it difficult to build big biotech from scratch. But sustainable biopharma firms are nevertheless emerging--mostly through the transformation of existing pharma assets.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Adamis Pharmaceuticals Corp.
  • Senior Management
  • Richard C Williams, CEO
    Robert J Caso, VP, Fin. & CFO
    Frank J Malinoski, MD, PhD, VP, R&D
  • Contact Info
  • Cellegy Pharmaceuticals Inc.
    Phone: (650) 616-2200
    1000 Marina Blvd.
    Ste. 300
    Brisbane, CA 94005
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register